Academic literature on the topic 'Dysgalacticin'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Dysgalacticin.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Dysgalacticin"

1

Heng, Nicholas C. K., Nancy L. Ragland, Pearl M. Swe, Hayley J. Baird, Megan A. Inglis, John R. Tagg, and Ralph W. Jack. "Dysgalacticin: a novel, plasmid-encoded antimicrobial protein (bacteriocin) produced by Streptococcus dysgalactiae subsp. equisimilis." Microbiology 152, no. 7 (July 1, 2006): 1991–2001. http://dx.doi.org/10.1099/mic.0.28823-0.

Full text
Abstract:
Dysgalacticin is a novel bacteriocin produced by Streptococcus dysgalactiae subsp. equisimilis strain W2580 that has a narrow spectrum of antimicrobial activity directed primarily against the principal human streptococcal pathogen Streptococcus pyogenes. Unlike many previously described bacteriocins of Gram-positive bacteria, dysgalacticin is a heat-labile 21.5 kDa anionic protein that kills its target without inducing lysis. The N-terminal amino acid sequence of dysgalacticin [Asn-Glu-Thr-Asn-Asn-Phe-Ala-Glu-Thr-Gln-Lys-Glu-Ile-Thr-Thr-Asn-(Asn)-Glu-Ala] has no known homologue in publicly ava
APA, Harvard, Vancouver, ISO, and other styles
2

Swe, Pearl M., Nicholas C. K. Heng, Gregory M. Cook, John R. Tagg, and Ralph W. Jack. "Identification of DysI, the Immunity Factor of the Streptococcal Bacteriocin Dysgalacticin." Applied and Environmental Microbiology 76, no. 23 (October 8, 2010): 7885–89. http://dx.doi.org/10.1128/aem.01707-10.

Full text
Abstract:
ABSTRACT DysI is identified as the protein that confers specific immunity to dysgalacticin, a plasmid-encoded streptococcal bacteriocin. dysI is transcribed as part of the copG-repB-dysI replication-associated operon. DysI appears to function at the membrane level to prevent the inhibitory effects of dysgalacticin on glucose transport, membrane integrity, and intracellular ATP content.
APA, Harvard, Vancouver, ISO, and other styles
3

Swe, P. M., G. M. Cook, J. R. Tagg, and R. W. Jack. "Mode of action of dysgalacticin: a large heat-labile bacteriocin." Journal of Antimicrobial Chemotherapy 63, no. 4 (February 17, 2009): 679–86. http://dx.doi.org/10.1093/jac/dkn552.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Vogel, Verena, and Barbara Spellerberg. "Bacteriocin Production by Beta-Hemolytic Streptococci." Pathogens 10, no. 7 (July 9, 2021): 867. http://dx.doi.org/10.3390/pathogens10070867.

Full text
Abstract:
Beta-hemolytic streptococci cause a variety of infectious diseases associated with high morbidity and mortality. A key factor for successful infection is host colonization, which can be difficult in a multispecies environment. Secreting bacteriocins can be beneficial during this process. Bacteriocins are small, ribosomally produced, antimicrobial peptides produced by bacteria to inhibit the growth of other, typically closely related, bacteria. In this systematic review, bacteriocin production and regulation of beta-hemolytic streptococci was surveyed. While Streptococcus pyogenes produces eigh
APA, Harvard, Vancouver, ISO, and other styles
5

Rutherford, S. J., A. N. Rycroft, and A. L. Ridler. "Sources ofStreptococcus dysgalactiaein English and Welsh sheep flocks affected by infectious arthritis (joint ill)." Veterinary Record 174, no. 23 (March 11, 2014): 579. http://dx.doi.org/10.1136/vr.101753.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Boehm, Teresa M. S. A., Christoph J. Klinger, Christine Gohl, Maike Lücht, Katja N. Baumann, and Ralf S. Mueller. "Topical treatment of multiple erosive, ulcerative skin lesions in an Indian rhinoceros (Rhinoceros unicornis)." Tierärztliche Praxis Ausgabe G: Großtiere / Nutztiere 49, no. 03 (June 2021): 210–14. http://dx.doi.org/10.1055/a-1475-3459.

Full text
Abstract:
AbstractA 30-year-old, intact female Indian rhinoceros (Rhinocerus unicornis) was presented with ongoing erosive, ulcerative skin lesions over a 4-year-period. The lesions appeared to be non-pruritic and non-seasonal. A systemic antibiotic therapy had been unsuccessful. The dermatological examination showed 8 diffusely demarcated areas of erosion, focal ulceration, mild crusting, and moderate erythema ranging from 8 to 20 cm in diameter, bilaterally on the lateral edges of the torso armor plates. The patient had no other clinical abnormalities. Coccoid and rod-shaped bacteria were identified o
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Dysgalacticin"

1

Swe, Pearl M., and n/a. "Mode of action of dysgalacticin and mechanism of its producer cell immunity." University of Otago. Department of Microbiology & Immunology, 2008. http://adt.otago.ac.nz./public/adt-NZDU20081119.111402.

Full text
Abstract:
Dysgalacticin is a large, 21.5 kDa bacteriocin that belongs to subgroup B of the class III bacteriocins. It is ribosomally produced by Streptococcus dysgalactiae subsp. equisimilis strain W2580 and exerts inhibitory activity mainly against the medically important pathogen Streptococcus pyogenes by a "non-lytic" mechanism. Despite numerous studies of the mechanisms of action of a wide variety of bacteriocins and of the basis of their producer strain self-immunity, relatively little is known about the "non-lytic" class of bacteriocins. The structural gene encoding for dysgalacticin (dysA) was kn
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!